Clearmind Medicine Inc. — Form D

Clearmind Medicine Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-07. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-02-07
• Form: D
• Accession: 0001213900-24-010974
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.4M
• Amount sold: $2.4M
• Investors: 12
• Date of first sale: 2024-01-11
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-504615

Issuer

• Name: Clearmind Medicine Inc.
• CIK: 0001892500
• Entity type: Corporation
• Jurisdiction: CANADA (FEDERAL LEVEL)
• Address: 101 - 1220 WEST 6TH AVENUE, VANCOUVER, A1, V6H1A5
• Phone: 973.536.1016

Officers, directors & promoters (7)

More

• CIK 1892500 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search